CN105616655A - 一种用于血瘀体质的药食配方 - Google Patents
一种用于血瘀体质的药食配方 Download PDFInfo
- Publication number
- CN105616655A CN105616655A CN201610018386.8A CN201610018386A CN105616655A CN 105616655 A CN105616655 A CN 105616655A CN 201610018386 A CN201610018386 A CN 201610018386A CN 105616655 A CN105616655 A CN 105616655A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood stasis
- blood
- radix
- body constitution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 76
- 210000004369 blood Anatomy 0.000 title claims abstract description 76
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 17
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 17
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 16
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 16
- 235000013305 food Nutrition 0.000 claims abstract description 16
- 235000008434 ginseng Nutrition 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims description 31
- 241000208340 Araliaceae Species 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 14
- 210000000582 semen Anatomy 0.000 claims description 14
- 239000008187 granular material Substances 0.000 claims description 12
- 230000008602 contraction Effects 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 235000019890 Amylum Nutrition 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000005453 pelletization Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 229920006300 shrink film Polymers 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 12
- 230000008901 benefit Effects 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 4
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 235000004789 Rosa xanthina Nutrition 0.000 abstract 1
- 241000109329 Rosa xanthina Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000004526 pharmaceutical effect Effects 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 20
- 230000001737 promoting effect Effects 0.000 description 17
- 235000009508 confectionery Nutrition 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 230000004087 circulation Effects 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000003266 anti-allergic effect Effects 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010049949 Intercostal neuralgia Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038419 Renal colic Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003257 anti-anginal effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000008344 brain blood flow Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000019590 thick flavour Nutrition 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种用于血瘀体质的药食配方,是由如下重量份数的原料组成的:桃仁5-10份、人参3-9份、陈皮3-10份、玫瑰花2-6份、龙眼肉9-15份、葛根10-15份、山楂9-12份、大枣6-15份、甘草(炙)2-10份。本发明提供的用于血瘀体质的药食配方,根据中医药的配伍原则,将九味中药进行组方,有效增强各成分的原有药效,使各成分相辅相成,产生良好的协同作用,对活血化瘀具有显著作用。另外,该药食配方所用的原料均来源于国家药食两用目录,安全无毒,能有效弥补单一组分食品的功效局限性,对血瘀体质有较为明显的作用,具有潜在的社会效益和经济效益。
Description
技术领域
本发明涉及食品技术领域,尤其涉及一种用于血瘀体质的药食两用配方。
背景技术
现代社会由于各种不良生活习惯(如工作环境寒冷等),以及七情不调、长期服药、久病不愈等原因,越来越多的人会出现血瘀症状。如若您经常出现心胸满闷,常见皮肤颜色晦暗,有色素沉着,肢体经常麻木,身体易于出现瘀斑,口唇颜色黯淡,舌色较黯而有瘀点,舌下脉络明显,脉涩等症状,那您很可能属于血瘀体质。这种体质的人有的经常烦躁易怒,女性多见经前期乳房胀痛、腹部刺痛、易得单纯性肥胖、黄褐斑、雀斑、经前期综合症等。有的身体出现刺痛,遇冷加重,易得偏头痛、胸痹、肋间神经痛、急性胃肠痉挛、女子痛经、经期延后等疾病,还有的常见口燥咽干、发热、出现各种疼痛,易得急性胃肠炎、胆石症、肾结石、血尿、肾绞痛、中风、肿瘤、女性盆腔炎及急性泌尿生殖系统感染等疾病。
血瘀体质是指体内存在血液运行不畅的潜在倾向或瘀血内阻的病理基础,以瘀血表现为主要特征的体质状态。一般体型偏瘦者居多,血瘀体质者常见表情抑郁、呆板,面部肌肉不灵活,容易健忘,记忆力下降,还经常出现心烦易怒等症状。
血瘀体质可由先天禀赋造成,也可因长期服药,加重肝脏负担,使肝脏长期受累而产生。此外,情绪抑郁,使肝脏功能长期不舒展,以及久病不愈,血瘀在微循环产生,受到严重创伤而瘀血不散,生活环境寒冷使血脉受寒凝滞等均可引造成血瘀体质的出现。血瘀体质者体内出现瘀血后,瘀塞在什么部位,什么部位就发暗、发青、疼痛、干燥瘙痒、出现肿物包块,此部位的功能也会受到影响。
发明内容
本发明的目的在于提供一种用于血瘀体质的药食配方,原料成本低廉,使用方便,实用,能够有效活血化瘀,无毒副作用。
为实现本发明的上述目的,本发明提供一种用于血瘀体质的药食配方,是由如下重量份数的原料组成的:桃仁5-10份、人参3-9份、陈皮3-10份、玫瑰花2-6份、龙眼肉9-15份、葛根10-15份、山楂9-12份、大枣6-15份、甘草(炙)2-10份。
所述用于血瘀体质的药食配方可制成饮品、食品、药品等。
所述用于血瘀体质的药食配方的制备方法,包括以下步骤。
步骤1、预处理:凭生产指令领取物料并核对物料代号、品名、规格、编号和重量等,并进行去外衣和消毒。
步骤2、制粒:按配方比例取桃仁、人参、陈皮、玫瑰花、龙眼肉、葛根、山楂、大枣、甘草(炙)原料放入混合制粒机中进行制粒。
步骤3、干燥:制粒后,进行干燥处理,干燥温度控制在35-40℃。
步骤4、整粒:将干燥后的物料在整粒机中进行整粒处理。
步骤5、混合填充:将步骤4整粒后的物料,添加乳糖、可压性淀粉、微粉硅胶等辅料后,在混合机中混合均匀,然后在自动包装机上进行包装。
步骤6、热收缩:将做好的小包装产品打好相应生产日期,套好热收缩膜进行热收缩。
步骤7、金属探测:将热收缩后的产品放在食品金属探测器上进行检测,然后包装打包,得成品。
步骤8、入库:成品放入库房的产品合格区。
在本发明的组方中。
桃仁:苦、甘,平。归心、肝、大肠经。活血祛瘀,润肠通便,止咳平喘。用于经闭痛经,癥瘕痞块,肺痈肠痈,跌扑损伤,肠燥便秘,咳嗽气喘。药理研究表明,桃仁可改善微循环,抗凝血,抗血栓形成,抗炎,抗过敏,润滑肠道,镇咳。
人参:甘、微苦,微温。归脾、肺、心、肾经。大补元气,复脉固脱,补脾益肺,生津养血,安神益智。用于体虚欲脱,肢冷脉微,脾虚食少,肺虚喘咳,津伤口渴,内热消渴,气血亏虚,久病虚羸,惊悸失眠,阳痿宫冷。现代药理研究人参主要成分为人参皂苷,能增强机体免疫功能,又具有抗休克、强心、健脑、抗疲劳作用。还可以能促进蛋白质合成,促进造血功能;亦有抗炎、抗过敏、抗肿瘤等多种作用。
陈皮:苦、辛,温。归肺、脾经。理气健脾,燥湿化痰。用于脘腹胀满,食少吐泻,咳嗽痰多。陈皮小量煎剂可增强心脏收缩力,使心输出量增加,冠脉流量增加,大剂量时可抑制心脏;提取物有清除氧自由基和抗脂质过氧化作用;陈皮煎剂有利胆、降脂作用;促进消化液的分泌、对肠管有解痉作用。
玫瑰花:味甘、微苦,性温。归脾、肝经。疏肝解郁,活血止痛。用于肝胃气痛,食少呕恶,月经不调,跌扑伤痛。玫瑰花能抗病毒作用,有促进胆汁分泌作用,有抗肿瘤作用。
葛根:甘、辛,凉。归脾、胃、肺经。解肌退热,生津止渴,透疹,升阳止泻,通经活络,解酒毒。用于外感发热头痛,项背强痛,口渴,消渴,麻疹不透,热痢,泄泻,眩晕头痛,中风偏瘫,胸痹心痛,酒毒伤中。葛根具有降血压、抗心律失常、抗心绞痛作用;能改善脑血循环,提高学习记忆功能;具有明显解热作用;有降糖、降脂作用;能抑制血小板聚集;有抗氧化、抗缺氧、抗癌及解毒作用。
山楂:酸、甘,微温。归脾、胃、肝经。消食健脾,行气散瘀,化浊降脂。用于肉食积滞,胃脘胀满,泻痢腹痛,瘀血经闭,产后瘀阻,心腹刺痛,胸痹心痛,疝气疼痛,髙脂血症。山楂有促进消化作用,能增加冠脉流量,降低心肌耗氧量,能降压,降脂,抗氧化,增强免疫,抗菌,防癌,增强睡眠,有收缩子宫、促进子宫复原、止痛作用。
龙眼肉:甘,温。归心、脾经。补益心脾,养血安神。用于气血不足,心悸怔忡,健忘失眠,血虚萎黄。现代药理研究表明,龙眼肉对小鼠遭受低温、高温、缺氧刺激有明显保护作用,并可增加小鼠体重;可增加小鼠静脉注射碳粒的廓清率,并能增加小鼠脾重。
大枣:甘,温。归脾、胃、心经。补中益气,养血安神。用于脾虚食少,乏力便溏,妇人脏躁。药理研究表明,大枣具有镇静催眠作用;有护肝作用;能增强肌力;抗变态反应;抗肿瘤;可清除自由基,有抗疲劳、抗衰老作用。
甘草:味甘,性平。归心、肺、脾、胃经。补脾益气,淸热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。本品药理作用有抗病毒、抗菌、抗溃疡、护肝降脂、缓解胃肠平滑肌痉挛、镇痛、抗炎、抗过敏、抗心率失常、镇咳祛痰、抗肿瘤、解毒、抗氧化等多重作用。
本发明组方的配伍释义:桃仁为君,味苦性甘平,能活血祛瘀,且润肠通便,使瘀血从下而走。人参、陈皮、玫瑰花为臣。气为血之帅,血为气之母,气行则血行,《本草纲目》言陈皮“其治百病,总取其理气燥湿之功”。故用陈皮行气,助君药活血化瘀之功。肝主藏血,可调节血量,故用玫瑰花,疏肝解郁,活血止痛,增强君药活血祛瘀之力,用人参,大补元气,生津养血,在行气活血化瘀同时补气补血,使活血有源,行气有根,三药共用为臣。葛根、山楂、龙眼肉、大枣、甘草为佐使。葛根功专解肌,可祛在肌肉腠理间之瘀血;山楂,消食健脾,行气散瘀,化浊降脂,可散脏腑经络间之瘀血。二药配合,助君臣药,祛全身瘀血。血瘀体质多见形体消瘦者,形不足者补之以味,故用甘温之龙眼肉、大枣为佐,龙眼肉补益心脾,养血安神,大枣补中益气,养血安神,二药共用,气血双补,强壮本源,使全方泻中有补。甘草甘平,益气和中,调和诸药,为使。全方泻中有补,可益气活血,行气散瘀,养血安神,化浊降脂,为血瘀体质调理佳品。
与现有技术相比本发明的有益效果。
本发明提供的用于血瘀体质的药食配方,根据中医药的配伍原则,将九味中药进行组方,有效增强各成分的原有药效,使各成分相辅相成,产生良好的协同作用,对活血化瘀具有显著作用。另外,该药食配方所用的原料均来源于国家药食两用目录,安全无毒,能有效弥补单一组分食品的功效局限性,对特血瘀体质有较为明显的作用,具有潜在的社会效益和经济效益。
具体实施方式
下面结合具体实施例进一步详细说明本发明。
实施例1。
本实施例提供一种用于血瘀体质的药食配方,是由如下重量份数的原料组成的:桃仁9份、人参6份、陈皮6份、玫瑰花6份、龙眼肉9份、葛根12份、山楂9份、大枣6份、甘草(炙)3份。
所述用于血瘀体质的药食配方的制备方法,包括以下步骤。
步骤1、预处理:凭生产指令领取物料并核对物料代号、品名、规格、编号和重量等,并进行去外衣和消毒。
步骤2、制粒:按配方取桃仁、人参、陈皮、玫瑰花、龙眼肉、葛根、山楂、大枣、甘草(炙)原料放入混合制粒机中进行制粒。
步骤3、干燥:制粒后,进行干燥处理,干燥温度控制在38℃。
步骤4、整粒:将干燥后的物料在整粒机中进行整粒处理。
步骤5、混合填充:将步骤4整粒后的物料,添加乳糖、可压性淀粉、微粉硅胶等辅料后,在混合机中混合均匀,然后在自动包装机上进行包装。
步骤6、热收缩:将做好的小包装产品打好相应生产日期,套好热收缩膜进行热收缩。
步骤7、金属探测:将热收缩后的产品放在食品金属探测器上进行检测,然后包装打包,得成品。
步骤8、入库:成品放入库房的产品合格区。
临床研究:经过专家诊断为血瘀质患者50例,主要症状为面色萎黄或淡白,头晕眼花,失眠多梦,手足麻木,口唇爪甲淡白,舌淡脉细。采用本实施例1用于血瘀体质的药食配方进行调理,每天食用40g,分两次服用,二个月后症状均明显改善。
实施例2。
本实施例提供一种用于血瘀体质的药食配方,是由如下重量份数的原料组成的:桃仁5份、人参4份、陈皮3份、玫瑰花2份、龙眼肉10份、葛根10份、山楂9份、大枣6份、甘草(炙)2份。
实施例3。
本实施例提供一种用于血瘀体质的药食配方,是由如下重量份数的原料组成的:桃仁10份、人参9份、陈皮9份、玫瑰花5份、龙眼肉15份、葛根15份、山楂12份、大枣15份、甘草(炙)10份。
Claims (6)
1.一种用于血瘀体质的药食配方,其特征在于,是由如下重量份数的原料组成的:桃仁5-10份、人参3-9份、陈皮3-10份、玫瑰花2-6份、龙眼肉9-15份、葛根10-15份、山楂9-12份、大枣6-15份、甘草(炙)2-10份。
2.如权利要求1所述的用于血瘀体质的药食配方,其特征在于,是由如下重量份数的原料组成的:桃仁9份、人参6份、陈皮6份、玫瑰花6份、龙眼肉9份、葛根12份、山楂9份、大枣6份、甘草(炙)3份。
3.如权利要求2所述的用于血瘀体质的药食配方,其特征在于,是由如下原料组成的:桃仁5份、人参4份、陈皮3份、玫瑰花2份、龙眼肉10份、葛根10份、山楂9份、大枣6份、甘草(炙)2份。
4.如权利要求3所述的用于血瘀体质的药食配方,其特征在于,是由如下原料组成的:桃仁10份、人参9份、陈皮9份、玫瑰花5份、龙眼肉15份、葛根15份、山楂12份、大枣15份、甘草(炙)10份。
5.如权利要求1-4所述的用于血瘀体质的药食配方的制备方法,其特征在于,包括以下步骤:
步骤1、预处理:凭生产指令领取物料并核对物料代号、品名、规格、编号和重量等,并进行去外衣和消毒;
步骤2、制粒:按配方比例取桃仁、人参、陈皮、玫瑰花、龙眼肉、葛根、山楂、大枣、甘草(炙)原料放入混合制粒机中进行制粒;
步骤3、干燥:制粒后,进行干燥处理,干燥温度控制在35-40℃;
步骤4、整粒:将干燥后的物料在整粒机中进行整粒处理;
步骤5、混合填充:将步骤4整粒后的物料,添加乳糖、可压性淀粉、微粉硅胶等辅料后,在混合机中混合均匀,然后在自动包装机上进行包装;
步骤6、热收缩:将做好的小包装产品打好相应生产日期,套好热收缩膜进行热收缩;
步骤7、金属探测:将热收缩后的产品放在食品金属探测器上进行检测,然后包装打包,得成品;
步骤8、入库:成品放入库房的产品合格区。
6.如权利要求1所述的用于血瘀体质的药食配方,其特征在于,所述用于血瘀体质的药食配方可制成饮品、食品、药品等。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610018386.8A CN105616655A (zh) | 2016-01-13 | 2016-01-13 | 一种用于血瘀体质的药食配方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610018386.8A CN105616655A (zh) | 2016-01-13 | 2016-01-13 | 一种用于血瘀体质的药食配方 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105616655A true CN105616655A (zh) | 2016-06-01 |
Family
ID=56032267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610018386.8A Pending CN105616655A (zh) | 2016-01-13 | 2016-01-13 | 一种用于血瘀体质的药食配方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105616655A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106538766A (zh) * | 2016-10-18 | 2017-03-29 | 张祺 | 血瘀体质茶饮 |
CN107048142A (zh) * | 2017-06-12 | 2017-08-18 | 安徽明珍堂养生品有限公司 | 一种调理血瘀体质的养生固体饮料及其制备方法 |
CN109527588A (zh) * | 2017-09-21 | 2019-03-29 | 广州市紫石智能科技有限公司 | 一种改善血瘀体质的食品及其制备工艺 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104256612A (zh) * | 2014-10-11 | 2015-01-07 | 王�琦 | 一种改善血瘀体质的食品及其制备工艺 |
CN105030970A (zh) * | 2015-08-17 | 2015-11-11 | 贵州广济堂药业有限公司 | 调理血瘀体质的保健品 |
-
2016
- 2016-01-13 CN CN201610018386.8A patent/CN105616655A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104256612A (zh) * | 2014-10-11 | 2015-01-07 | 王�琦 | 一种改善血瘀体质的食品及其制备工艺 |
CN105030970A (zh) * | 2015-08-17 | 2015-11-11 | 贵州广济堂药业有限公司 | 调理血瘀体质的保健品 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106538766A (zh) * | 2016-10-18 | 2017-03-29 | 张祺 | 血瘀体质茶饮 |
CN107048142A (zh) * | 2017-06-12 | 2017-08-18 | 安徽明珍堂养生品有限公司 | 一种调理血瘀体质的养生固体饮料及其制备方法 |
CN109527588A (zh) * | 2017-09-21 | 2019-03-29 | 广州市紫石智能科技有限公司 | 一种改善血瘀体质的食品及其制备工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102125147B (zh) | 一种保健茶 | |
CN105288324A (zh) | 一种用于阴虚体质的药食配方 | |
CN104666768B (zh) | 一种用于滋养气血的中药保健制剂 | |
CN106343113A (zh) | 一种人参养生保健美容茶及其制备方法 | |
CN105456822A (zh) | 一种育阴扶阳养生黄酒 | |
CN102550738B (zh) | 一种可防辐射、提高免疫力的保健茶及其制备方法 | |
CN104940645A (zh) | 一种具有美容养颜功能的铁皮石斛中药组合物及其制剂 | |
CN102366538A (zh) | 一种补血养颜中药制剂及制备方法 | |
CN105616655A (zh) | 一种用于血瘀体质的药食配方 | |
CN105595339A (zh) | 一种用于气虚体质的药食配方 | |
CN104605361B (zh) | 调节人体亚健康状态的组合物及使用其制备饮料的方法 | |
CN105920269A (zh) | 一种女性保健药酒 | |
CN103156956B (zh) | 一种补血口服液及制备方法 | |
CN102872368B (zh) | 一种用于泻火解毒的中药贴敷制剂 | |
CN104187246A (zh) | 一种功能性红糖及其制备方法 | |
CN106492175A (zh) | 一种治疗肝郁脾虚的中药 | |
CN100998693B (zh) | 一种中药保健药酒 | |
CN102766561B (zh) | 茯苓补骨营养酒及制备方法 | |
CN104840686A (zh) | 一种降压保健茶 | |
CN101279007B (zh) | 一种治疗小便失禁的中药药物 | |
CN104840902A (zh) | 一种治疗卵巢肿瘤的中药制剂 | |
CN104173745A (zh) | 一种滋补健身的蒙药 | |
CN103525642A (zh) | 一种黑芝麻健脾益气酒的配方及生产方法 | |
CN104225204A (zh) | 一种由枸杞、菊花、山药和麦冬制成的保健品 | |
CN101810751B (zh) | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20161207 Address after: 117000 Xin'an street, Huanren Manchu Autonomous County, Benxi, Liaoning, China Applicant after: Liaoning good nurse Biotechnology Co., Ltd. Address before: 117200 Taishan County, Liaoning Province, the economic development zone, the five female mountain road, No. 6, Applicant before: Liaoning medicine good nurse (Group) Co. Ltd. |
|
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160601 |
|
RJ01 | Rejection of invention patent application after publication |